Biomarker changes during acute heart failure treatment.

Item

http://www.wikidata.org/entity/Q35854988

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Biomarker changes during acute heart failure treatment.

@ast

Biomarker changes during acute heart failure treatment.

@en

type

Item

label

Biomarker changes during acute heart failure treatment.

@ast

Biomarker changes during acute heart failure treatment.

@en

prefLabel

Biomarker changes during acute heart failure treatment.

@ast

Biomarker changes during acute heart failure treatment.

@en

P1476

Biomarker changes during acute heart failure treatment

@en

P2093

Brent Boyer

http://www.w3.org/2001/XMLSchema#string

Kimberly W Hart

http://www.w3.org/2001/XMLSchema#string

Matthew I Sperling

http://www.w3.org/2001/XMLSchema#string

Sean P Collins

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

Biomarkers in heart failure

Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure.

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

HFSA 2006 Comprehensive Heart Failure Practice Guideline.

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes.

P304

91-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1751-7133.2011.00256.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher John Lindsell

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221876202

http://www.w3.org/2001/XMLSchema#string

P698

22432555

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

biomarker

P932

3313068

http://www.w3.org/2001/XMLSchema#string